- Home
- BBIO vs URBN Comparison
BBIO vs URBN Comparison
Compare BBIO & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- URBN
- Stock Information
- Founded
- BBIO 2015
- URBN 1970
- Country
- BBIO United States
- URBN United States
- Employees
- BBIO N/A
- URBN N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- URBN Clothing/Shoe/Accessory Stores
- Sector
- BBIO Health Care
- URBN Consumer Discretionary
- Exchange
- BBIO Nasdaq
- URBN Nasdaq
- Market Cap
- BBIO 5.6B
- URBN 5.1B
- IPO Year
- BBIO 2019
- URBN 1993
- Fundamental
- Price
- BBIO $36.85
- URBN $52.80
- Analyst Decision
- BBIO Strong Buy
- URBN Buy
- Analyst Count
- BBIO 12
- URBN 11
- Target Price
- BBIO $52.27
- URBN $53.64
- AVG Volume (30 Days)
- BBIO 2.7M
- URBN 1.4M
- Earning Date
- BBIO 02-20-2025
- URBN 02-26-2025
- Dividend Yield
- BBIO N/A
- URBN N/A
- EPS Growth
- BBIO N/A
- URBN 20.71
- EPS
- BBIO N/A
- URBN 3.49
- Revenue
- BBIO $221,902,000.00
- URBN $5,400,740,000.00
- Revenue This Year
- BBIO $2,306.75
- URBN $9.66
- Revenue Next Year
- BBIO N/A
- URBN $6.37
- P/E Ratio
- BBIO N/A
- URBN $15.10
- Revenue Growth
- BBIO 2285.27
- URBN 6.91
- 52 Week Low
- BBIO $21.62
- URBN $33.86
- 52 Week High
- BBIO $39.47
- URBN $60.90
- Technical
- Relative Strength Index (RSI)
- BBIO 63.77
- URBN 41.01
- Support Level
- BBIO $35.36
- URBN $54.53
- Resistance Level
- BBIO $39.47
- URBN $57.63
- Average True Range (ATR)
- BBIO 1.93
- URBN 1.76
- MACD
- BBIO 0.26
- URBN -0.41
- Stochastic Oscillator
- BBIO 70.79
- URBN 8.34
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About URBN Urban Outfitters Inc.
Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States (87.5% of fiscal 2024 sales) and other regions. Its retail nameplates are Urban Outfitters, Free People, FP Movement, and Anthropologie. Retail accounted for 91% of fiscal 2024 revenue, but the firm also sells products through a wholesale operation, owns some restaurants, and operates a clothing rental and resale business called Nuuly (5% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.